D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 23,467 304 World Ranking 8444 National Ranking 270

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of investigation include Gynecology, Mass screening, Internal medicine, Breast cancer and Mammography. His Gynecology research incorporates themes from Psychological intervention, Cancer, Observational study, Annual Screening and Overdiagnosis. His Internal medicine study frequently intersects with other fields, such as Oncology.

His Breast cancer research incorporates elements of Cancer screening and Obstetrics. His biological study spans a wide range of topics, including Mortality rate and Gerontology. His research integrates issues of Rate ratio and Prostate in his study of Prostate cancer.

His most cited work include:

  • Screening and Prostate-Cancer Mortality in a Randomized European Study (3160 citations)
  • Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition (1389 citations)
  • Prostate-Cancer Mortality at 11 Years of Follow-up (964 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Breast cancer, Gynecology, Mass screening and Mammography. His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Stage. Breast cancer is a subfield of Cancer that Harry J. de Koning tackles.

His Mass screening research is multidisciplinary, incorporating elements of Overdiagnosis, Radiology and Annual Screening. His Prostate cancer research includes elements of Biopsy and Prostate. His work deals with themes such as Physical therapy, Clinical trial, Epidemiology and Lung cancer, Lung cancer screening, which intersect with Randomized controlled trial.

He most often published in these fields:

  • Internal medicine (36.13%)
  • Breast cancer (23.56%)
  • Gynecology (23.56%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (36.13%)
  • Lung cancer (15.71%)
  • Lung cancer screening (17.28%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Lung cancer, Lung cancer screening, Breast cancer and Incidence. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology. His Lung cancer research is multidisciplinary, incorporating perspectives in Psychological intervention, Cancer, Cancer screening, Economic evaluation and Lung.

His work on Breast cancer screening as part of general Breast cancer study is frequently linked to Statement, bridging the gap between disciplines. Harry J. de Koning has included themes like Observational study and Mass screening in his Breast cancer screening study. His research in the fields of Prostate-specific antigen and Prostate cancer screening overlaps with other disciplines such as Micro simulation.

Between 2018 and 2021, his most popular works were:

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer (95 citations)
  • Supplemental MRI Screening for Women with Extremely Dense Breast Tissue (90 citations)
  • Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review (24 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Internal medicine, Incidence, Lung cancer, Breast cancer and Lung cancer screening are his primary areas of study. His Internal medicine study frequently draws connections between related disciplines such as Mortality reduction. His Incidence research integrates issues from Epidemiology, Colposcopy, Randomized controlled trial, Confidence interval and Overdiagnosis.

His work carried out in the field of Randomized controlled trial brings together such families of science as Affect, Rate ratio, Prostate-specific antigen, Prostate cancer and Screening Trial. His biological study spans a wide range of topics, including Cancer, Area under the curve, Nodule and Trial registration. His Breast cancer study combines topics in areas such as Nursing, Biopsy, Oncology and Mass screening.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Screening and Prostate-Cancer Mortality in a Randomized European Study

Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2009)

4796 Citations

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard.
The New England Journal of Medicine (2004)

1985 Citations

Prostate-Cancer Mortality at 11 Years of Follow-up

Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2012)

1570 Citations

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W. van der Cruijsen.
Journal of the National Cancer Institute (2003)

1295 Citations

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

Gerrit Draisma;Ruth Etzioni;Alex Tsodikov;Angela Mariotto.
Journal of the National Cancer Institute (2009)

870 Citations

Management of lung nodules detected by volume CT scanning

Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten.
The New England Journal of Medicine (2009)

853 Citations

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

Jeanne S. Mandelblatt;Kathleen A. Cronin;Stephanie Bailey;Donald A. Berry.
Annals of Internal Medicine (2009)

658 Citations

Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

Harry J. de Koning;Rafael Meza;Sylvia K. Plevritis;Kevin ten Haaf.
Annals of Internal Medicine (2014)

450 Citations

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

Suzie J. Otto;Jacques Fracheboud;Caspar W. N. Looman;Mireille J. M. Broeders.
The Lancet (2003)

447 Citations

Prostate cancer detection at low prostate specific antigen.

Fritz H. Schröder;Ingrid van der Cruijsen-Koeter;Harry J. de Koning;André N. Vis.
The Journal of Urology (2000)

438 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Harry J. de Koning

Monique J. Roobol

Monique J. Roobol

Erasmus MC

Publications: 195

Fritz H. Schröder

Fritz H. Schröder

Erasmus MC

Publications: 178

Hans Lilja

Hans Lilja

Memorial Sloan Kettering Cancer Center

Publications: 91

Stephen W. Duffy

Stephen W. Duffy

Queen Mary University of London

Publications: 85

Matthijs Oudkerk

Matthijs Oudkerk

University of Groningen

Publications: 81

Constance D. Lehman

Constance D. Lehman

Harvard University

Publications: 79

Bram van Ginneken

Bram van Ginneken

Radboud University Nijmegen

Publications: 74

Andrew J. Vickers

Andrew J. Vickers

Memorial Sloan Kettering Cancer Center

Publications: 71

Mathias Prokop

Mathias Prokop

Radboud University Nijmegen

Publications: 71

Freddie C. Hamdy

Freddie C. Hamdy

University of Oxford

Publications: 71

Chris H. Bangma

Chris H. Bangma

Erasmus University Rotterdam

Publications: 70

Anssi Auvinen

Anssi Auvinen

Tampere University

Publications: 69

David E. Neal

David E. Neal

University of Cambridge

Publications: 66

Teuvo L.J. Tammela

Teuvo L.J. Tammela

Tampere University

Publications: 64

Peter C. Albertsen

Peter C. Albertsen

University of Connecticut Health Center

Publications: 63

H. Ballentine Carter

H. Ballentine Carter

Johns Hopkins University School of Medicine

Publications: 62

Something went wrong. Please try again later.